BioLegend
Presence
Revvity is one of the...
Revvity is a company listed under the stock ticker RVTY (US).
Revvity has a direct presence in 2 countries.Revvity has 4 subsidiaries including BioLegend, Horizon Discovery and Immunodiagnostic Systems.
They are in:
- Biotechnology40%
- Healthcare20%
- Other40%
Executives
View the org chart displaying its 9 main executives
Most searched biographies at BioLegend
- Gene Lay, Chief Executive Officer
- Craig Monell, Senior Vice President, Business Operations
- Nancy Huang, Vice President, International Sales & Marketing
Popular executive movements at Revvity
- Sophie Vandebroek has joined the company as Director (posted on January 26 2024).
- Michael Klobuchar has joined the company as Director (posted on January 26 2024).
Create your alert
to follow the executive moves at BioLegend.
Biotechnology
Revvity has 2,296 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Johnson & Johnson has announced the acquisition of Proteologix (posted on May 20 2024).
- Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
Popular contacts in Biotechnology
News
Press releases by BioLegend
Social media about BioLegend
- BioLegend on Wikipedia, Google News & Yahoo Finance
- BioLegend on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Gene Lay 
